Warfarin news

All news on Warfarin: plants, production capacities, investments and involved companies.

26 June 2026

Novo Nordisk to present denecimig and concizumab data at ISTH 2026

Phase‑3 FRONTIER4 interim denecimig data across ages and monthly/biweekly/weekly dosing, plus first paediatric explorer10 concizumab 32‑week results for children up to 11 with inhibitors.

Who will be producing Warfarin in the future?

Find out with chemXplore Alpha

Learn more